Publicaciones en colaboración con investigadores/as de University of Birmingham (62)

2018

  1. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers

    Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34

  2. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

    Mayo Clinic Proceedings, Vol. 93, Núm. 8, pp. 1065-1073

  3. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

    International Journal of Clinical Practice, Vol. 72, Núm. 3

  4. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis

    Breast Cancer Research and Treatment, Vol. 169, Núm. 1, pp. 83-92

  5. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

    Journal of Internal Medicine, Vol. 283, Núm. 3, pp. 282-292

  6. Comparison of the 2MACE and TIMI-AF scores for composite clinical outcomes in anticoagulated atrial fibrillation patients

    Circulation Journal, Vol. 82, Núm. 5, pp. 1286-1292

  7. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

    American Journal of Cardiology, Vol. 122, Núm. 5, pp. 785-792

  8. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

    International Journal of Cardiology, Vol. 254, pp. 125-131

  9. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 48, Núm. 6

  10. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED

    American Heart Journal, Vol. 197, pp. 27-34

  11. Quality of oral anticoagulation with Vitamin K antagonists in 'real-world' patients with atrial fibrillation: A report from the prospective multicentre FANTASIIA registry

    Europace, Vol. 20, Núm. 9, pp. 1435-1441

  12. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

    Clinical Therapeutics, Vol. 40, Núm. 1, pp. 114-122

  13. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 2, pp. 279-287

  14. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

    Journal of General Internal Medicine, Vol. 33, Núm. 6, pp. 847-854

2017

  1. Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

    European Journal of Internal Medicine

  2. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based only on Modifiable Bleeding Risk Factors against the HAS-BLED ScoreThe AMADEUS Trial

    Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2261-2266

  3. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

    Thrombosis and Haemostasis, Vol. 117, Núm. 7, pp. 1448-1454

  4. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

  5. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

    Scientific Reports, Vol. 7, Núm. 1

  6. Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and abc-bleeding risk scores: The murcia atrial fibrillation project

    Thrombosis and Haemostasis, Vol. 117, Núm. 10, pp. 1848-1858